BioIntervene, Inc. — Form D
BioIntervene, Inc. of BRISBANE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-06-23. The offering totals $5.6M, of which $5.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-06-23
- Form: D
- Accession: 0001771460-21-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.6M
- Amount sold: $5.6M
- Investors: 3
- Date of first sale: 2021-06-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-403933
Issuer
- Name: BioIntervene, Inc.
- CIK: 0001771460
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: c/o MPM Capital, BRISBANE, CA, 94005
- Phone: 650-553-3300
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Gary J Bennett | Director | Brisbane, CA |
| David J Bredt | Director | Brisbane, CA |
| Ed Hurwitz | Director | San Diego, CA |
| Gary J Patou | Director | Brisbane, CA |
| Daniela J Salvemini | Director | Brisbane, CA |
| Simon J Tate | Director | Brisbane, CA |
| Gary J Bennett | Executive Officer | Brisbane, CA |
| Ed J Hurwitz | Director | San Diego, CA |
Other filings by this issuer (1)
More